ResearcherNetherlands Comprehensive Cancer OrganisationNo recent work listed

Natasja J. H. Raijmakers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3000-2520; OpenAlex author ID A5018445210. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper

Papers 1

Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands. Last author DOI 10.1080/0284186x.2018.1470330 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

V.E.P.P. Lemmens · 1 shared paper, 2018 · strength 0.10
- Paper Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands. DOI 10.1080/0284186x.2018.1470330 ↗
Hanneke W.M. van Laarhoven · 1 shared paper, 2018 · strength 0.10
- Paper Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands. DOI 10.1080/0284186x.2018.1470330 ↗
Lydia G. van der Geest · 1 shared paper, 2018 · strength 0.10
- Paper Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands. DOI 10.1080/0284186x.2018.1470330 ↗
Myrte Zijlstra · 1 shared paper, 2018 · strength 0.10
- Paper Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands. DOI 10.1080/0284186x.2018.1470330 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.